Zimmer Biomet Holdings (ZBH) Misses Q4 EPS by 3c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Zimmer Biomet (ZBH) PT Lowered to $128 at Truist Securities
February 8, 2022 6:38 AM ESTTruist Securities analyst Kaila Krum lowered the price target on Zimmer Biomet (NYSE: ZBH) to $128.00 (from $145.00) while maintaining a Buy rating following results.
The analyst commented, "We remain Buy rated following a noisy 4Q/'22 guide, which disappointed on a more sanguine COVID... More
